Lipkowitz S - Search Results

1

Loss of function Cbl-c mutations in solid tumors.

Daniels SR, Liyasova M, Kales SC, Nau MM, Ryan PE, Green JE, Lipkowitz S. Daniels SR, et al. Among authors: lipkowitz s. PLoS One. 2019 Jul 1;14(7):e0219143. doi: 10.1371/journal.pone.0219143. eCollection 2019. PLoS One. 2019. PMID: 31260484 Free PMC article.

2

Cloning and characterization of cbl-b: a SH3 binding protein with homology to the c-cbl proto-oncogene.

Keane MM, Rivero-Lezcano OM, Mitchell JA, Robbins KC, Lipkowitz S. Keane MM, et al. Among authors: lipkowitz s. Oncogene. 1995 Jun 15;10(12):2367-77. Oncogene. 1995. PMID: 7784085

3

Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.

Keane MM, Ettenberg SA, Nau MM, Russell EK, Lipkowitz S. Keane MM, et al. Among authors: lipkowitz s. Cancer Res. 1999 Feb 1;59(3):734-41. Cancer Res. 1999. PMID: 9973225

4

cbl-b inhibits epidermal growth factor receptor signaling.

Ettenberg SA, Keane MM, Nau MM, Frankel M, Wang LM, Pierce JH, Lipkowitz S. Ettenberg SA, et al. Among authors: lipkowitz s. Oncogene. 1999 Mar 11;18(10):1855-66. doi: 10.1038/sj.onc.1202499. Oncogene. 1999. PMID: 10086340

5

cbl-3: a new mammalian cbl family protein.

Keane MM, Ettenberg SA, Nau MM, Banerjee P, Cuello M, Penninger J, Lipkowitz S. Keane MM, et al. Among authors: lipkowitz s. Oncogene. 1999 Jun 3;18(22):3365-75. doi: 10.1038/sj.onc.1202753. Oncogene. 1999. PMID: 10362357

6

cbl-b inhibits EGF-receptor-induced apoptosis by enhancing ubiquitination and degradation of activated receptors.

Ettenberg SA, Rubinstein YR, Banerjee P, Nau MM, Keane MM, Lipkowitz S. Ettenberg SA, et al. Among authors: lipkowitz s. Mol Cell Biol Res Commun. 1999 Aug;2(2):111-8. doi: 10.1006/mcbr.1999.0157. Mol Cell Biol Res Commun. 1999. PMID: 10542134

7

Inhibition of NF-kappaB activity enhances TRAIL mediated apoptosis in breast cancer cell lines.

Keane MM, Rubinstein Y, Cuello M, Ettenberg SA, Banerjee P, Nau MM, Lipkowitz S. Keane MM, et al. Among authors: lipkowitz s. Breast Cancer Res Treat. 2000 Nov;64(2):211-9. doi: 10.1023/a:1006458407515. Breast Cancer Res Treat. 2000. PMID: 11194457

8

Synergistic induction of apoptosis by the combination of trail and chemotherapy in chemoresistant ovarian cancer cells.

Cuello M, Ettenberg SA, Nau MM, Lipkowitz S. Cuello M, et al. Among authors: lipkowitz s. Gynecol Oncol. 2001 Jun;81(3):380-90. doi: 10.1006/gyno.2001.6194. Gynecol Oncol. 2001. PMID: 11371126

9

Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex.

Ettenberg SA, Magnifico A, Cuello M, Nau MM, Rubinstein YR, Yarden Y, Weissman AM, Lipkowitz S. Ettenberg SA, et al. Among authors: lipkowitz s. J Biol Chem. 2001 Jul 20;276(29):27677-84. doi: 10.1074/jbc.M102641200. Epub 2001 May 24. J Biol Chem. 2001. PMID: 11375397 Free article.

10

Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2.

Cuello M, Ettenberg SA, Clark AS, Keane MM, Posner RH, Nau MM, Dennis PA, Lipkowitz S. Cuello M, et al. Among authors: lipkowitz s. Cancer Res. 2001 Jun 15;61(12):4892-900. Cancer Res. 2001. PMID: 11406568

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters